- UPC: 790011030522
|Jarro-Dophilus® Women |
A True Probiotic for Women Uniquely Formulated with Strains Naturally Found in a Woman’s Body*
Jarro-Dophilus® Women Function
Helps Restore Healthy Vaginal Flora & Promotes Urinary Tract Health*
Jarro-Dophilus® Women Highlights
Clinically Shown Effective at 5 - 10 Billion*
Contains 4 Patented & Clinically Documented Vaginal Strains in Each Capsule
Helps Restore Healthy Vaginal Flora*
Promotes Urinary Tract Health*
Lowers the pH of the Vagina*
What Does Jarro-Dophilus Women Do?
The Only True Women’s Probiotic With Four Strains Resident in the Healthy Vaginal Tract*
Jarro-Dophilus® Women combines the most prevalent vaginal lactobacilli species and has been clinically shown to be effective at 5 - 10 billion to help restore healthy vaginal flora.*
4 Clinically Documented, Beneficial Lactobacilli Strains From the Vagina
1... L. crispatus LbV 88
2... L. gasseri LbV 150N
3... L. jensenii LbV 116
4... L. rhamnosus LbV 96
Undesirable bacteria do not thrive in an acidic environment. Jarro-Dophilus® Women’s patented strains produce lactic acid and hydrogen peroxide (H202) and have been shown in clinical studies to lower vaginal pH, creating a mildly acidic and healthier microbial environment.*
For maintenance, take 1 capsule per day. Increase to 1 capsule twice daily as needed, or take as directed by your qualified healthcare professional.
Take at least 1-2 hours after taking antibiotics. Do not use these Enteric-Coated capsules for direct vaginal insertion.
Tapioca starch. Vegetarian capsule consists of hydroxypropylmethylcellulose. pH-sensitive enteric coating consists of modified cellulose, magnesium silicate, triethyl citrate, sodium alginate and cellulose gum.
No wheat, gluten, soybeans, dairy, egg, fish/shellfish, or peanuts/tree nuts.
Suitable for vegetarians/vegans.
Free of major allergens.
Coated with EnteroGuard®, a proprietary food-grade, pH-sensitive enteric coating that resists stomach acid.
Blister Packaged For Superior Stability
Protected by U.S. Patent 8,846,027 and European Patent 2,509,610, which are owned by HSO Health Care GmbH, Vienna, Austria, and licensed in the U.S. to Jarrow Formulas, Inc. Other international patents pending. Sold worldwide as Astarte.